Islam B, Sharman S, Hou Y, Wang R, Ashby J, Li H
Carcinogenesis. 2022; 43(6):584-593.
PMID: 35188962
PMC: 9234760.
DOI: 10.1093/carcin/bgac022.
Hou Y, Wren A, Mylarapu N, Browning K, Islam B, Wang R
J Pharmacol Exp Ther. 2022; 381(1):42-53.
PMID: 35110391
PMC: 8998686.
DOI: 10.1124/jpet.121.001075.
Rappaport J, Entezari A, Caspi A, Caksa S, Jhaveri A, Stanek T
Cell Mol Gastroenterol Hepatol. 2021; 13(4):1276-1296.
PMID: 34954189
PMC: 9073733.
DOI: 10.1016/j.jcmgh.2021.12.014.
Weinberg D, Foster N, DellaZanna G, McMurray R, Kraft W, Pallotto A
Cancer Biol Ther. 2021; 22(10-12):544-553.
PMID: 34632925
PMC: 8726613.
DOI: 10.1080/15384047.2021.1967036.
Entezari A, Snook A, Waldman S
Expert Opin Ther Targets. 2021; 25(5):335-346.
PMID: 34056991
PMC: 8363580.
DOI: 10.1080/14728222.2021.1937124.
GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer.
Lisby A, Flickinger Jr J, Bashir B, Weindorfer M, Shelukar S, Crutcher M
Expert Rev Precis Med Drug Dev. 2021; 6(2):117-129.
PMID: 34027103
PMC: 8133521.
DOI: 10.1080/23808993.2021.1876518.
Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.
Flickinger Jr J, Rappaport J, Barton J, Baybutt T, Pattison A, Snook A
Biomark Med. 2021; 15(3):201-217.
PMID: 33470843
PMC: 8293028.
DOI: 10.2217/bmm-2020-0359.
An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.
Rappaport J, Waldman S
Expert Rev Clin Pharmacol. 2020; 13(10):1125-1137.
PMID: 32945718
PMC: 7818552.
DOI: 10.1080/17512433.2020.1826304.
Silencing the intestinal GUCY2C tumor suppressor axis requires loss of heterozygosity.
Pattison A, Barton J, Entezari A, Zalewski A, Rappaport J, Snook A
Cancer Biol Ther. 2020; 21(9):799-805.
PMID: 32594830
PMC: 7515455.
DOI: 10.1080/15384047.2020.1779005.
APC-β-catenin-TCF signaling silences the intestinal guanylin-GUCY2C tumor suppressor axis.
Blomain E, Rappaport J, Pattison A, Bashir B, Caparosa E, Stem J
Cancer Biol Ther. 2020; 21(5):441-451.
PMID: 32037952
PMC: 7515458.
DOI: 10.1080/15384047.2020.1721262.
Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation.
Waldman S, Tenenbaum R, Foehl H, Winkle P, Griffin P
Clin Transl Gastroenterol. 2019; 10(7):e00016.
PMID: 31318728
PMC: 6708669.
DOI: 10.14309/ctg.0000000000000016.
The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.
Rappaport J, Waldman S
Front Oncol. 2018; 8:299.
PMID: 30131940
PMC: 6091576.
DOI: 10.3389/fonc.2018.00299.
Cyclic-GMP-Elevating Agents Suppress Polyposis in mice by Targeting the Preneoplastic Epithelium.
Sharman S, Islam B, Hou Y, Singh N, Berger F, Sridhar S
Cancer Prev Res (Phila). 2018; 11(2):81-92.
PMID: 29301746
PMC: 5811348.
DOI: 10.1158/1940-6207.CAPR-17-0267.
GUCY2C maintains intestinal LGR5 stem cells by opposing ER stress.
Kraft C, Rappaport J, Snook A, Pattison A, Lynch J, Waldman S
Oncotarget. 2017; 8(61):102923-102933.
PMID: 29262534
PMC: 5732700.
DOI: 10.18632/oncotarget.22084.
GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome.
Li P, Wuthrick E, Rappaport J, Kraft C, Lin J, Marszalowicz G
Cancer Res. 2017; 77(18):5095-5106.
PMID: 28916678
PMC: 5678756.
DOI: 10.1158/0008-5472.CAN-17-0859.
ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in Mice.
Li P, Lin J, Snook A, Waldman S
Toxins (Basel). 2017; 9(9).
PMID: 28895923
PMC: 5618212.
DOI: 10.3390/toxins9090279.
Sildenafil Suppresses Inflammation-Driven Colorectal Cancer in Mice.
Islam B, Sharman S, Hou Y, Bridges A, Singh N, Kim S
Cancer Prev Res (Phila). 2017; 10(7):377-388.
PMID: 28468928
PMC: 5530733.
DOI: 10.1158/1940-6207.CAPR-17-0015.
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.
Weinberg D, Lin J, Foster N, DellaZanna G, Umar A, Seisler D
Cancer Prev Res (Phila). 2017; 10(6):345-354.
PMID: 28396341
PMC: 5758862.
DOI: 10.1158/1940-6207.CAPR-16-0286.
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
Aka A, Rappaport J, Pattison A, Sato T, Snook A, Waldman S
Expert Rev Clin Pharmacol. 2017; 10(5):549-557.
PMID: 28162021
PMC: 5742255.
DOI: 10.1080/17512433.2017.1292124.
Guanylyl cyclase C signaling axis and colon cancer prevention.
Pattison A, Merlino D, Blomain E, Waldman S
World J Gastroenterol. 2016; 22(36):8070-7.
PMID: 27688649
PMC: 5037076.
DOI: 10.3748/wjg.v22.i36.8070.